SCHEMBL8348000

SCHEMBL8348000

SCCC1C=CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13025566 0.80
SCHEMBL9286912 0.78
SCHEMBL14793045 0.76
SCHEMBL7067973 0.76
SCHEMBL14535983 0.76
SCHEMBL18951468 0.74 SIGMAR1 (0.35)
SCHEMBL3439756 0.73 SIGMAR1 (0.31)
SCHEMBL13957201 0.73 SIGMAR1 (0.31)
SCHEMBL11578211 0.73
SCHEMBL28729089 0.71 FFAR3 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2599818-B1 Silicon-containing resist underlayer film-forming composition and patterning process SHINETSU CHEMICAL CO (JP) 2017-02-01 EP disclosed
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-8093028-B2 Engineered glycosyltransferases with expanded substrate specificity WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed
US-20090181854-A1 Engineered Glycosyltransferases With Expanded Substrate Specificity WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-07-16 US disclosed
WO-2007134485-A1 APORPHINE AND OXOAPORPHINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF LOTUS PHARMACEUTICAL CO., LTD. (CN) 2007-11-29 WO disclosed
WO-2003053437-A1 TRIAZOLES AS OXYTOCIN ANTAGONISTS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2003-07-03 WO disclosed